Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2017 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NATERA INC | 15 | Q2 2024 | 53.0% |
GUARDANT HEALTH INC | 15 | Q2 2024 | 21.3% |
AKOYA BIOSCIENCES INC | 11 | Q2 2024 | 23.4% |
ADAPTIVE BIOTECHNOLOGIES COR | 10 | Q1 2024 | 17.7% |
CAREDX INC | 8 | Q2 2024 | 19.0% |
MAXCYTE INC | 8 | Q2 2024 | 11.8% |
THERMO FISHER SCIENTIFIC INC | 6 | Q4 2023 | 16.0% |
BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
SC 13G | 2024-08-28 |
13F-HR | 2024-08-09 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.